DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

10817	Companies
234456	Keywords
163317	Articles
125457	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 06/03/2026 at 22:30, 2 months 7 days ago

DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026
DBV Technologies annonce les résultats de son Assemblée Générale Mixte du 3 juin 2026. Toutes les résolutions ont été adoptées. La société biopharmaceutique se concentre sur le traitement des allergies alimentaires

Assemblée Générale Mixte DBV Technologies Allergies Alimentaires Viaskin Résolutions Adoptées
PRESS RELEASE

published on 06/03/2026 at 22:30, 2 months 7 days ago

DBV Technologies Announces the Results of its 2026 Combined General Meeting
DBV Technologies announces successful results of its 2026 Combined General Meeting where all proposed resolutions were approved by shareholders. Visit the company's website for more details

Shareholders Resolutions DBV Technologies VIASKIN Patch 2026 Combined General Meeting
BRIEF

published on 06/03/2026 at 01:45, 2 months 8 days ago

DBV Technologies sélectionne le premier participant à l'étude THRIVE sur le patch anti-craquelins pour nourrissons.

Allergie Aux Arachides Technologies DBV Patch VIASKIN® À L'arachide Étude THRIVE Phase 2 Traitement Infantile
BRIEF

published on 06/03/2026 at 01:45, 2 months 8 days ago

DBV Technologies Screens First Participant in THRIVE Study of Peanut Patch for Infants

DBV Technologies Peanut Allergy VIASKIN® Peanut Patch THRIVE Phase 2 Study Infant Treatment
PRESS RELEASE

published on 06/03/2026 at 01:40, 2 months 8 days ago

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
DBV Technologies a annoncé le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons allergiques à l’arachide

Étude Clinique DBV Technologies Patch VIASKIN® Peanut Nourrissons Allergiques Phase 2 THRIVE
PRESS RELEASE

published on 06/03/2026 at 01:40, 2 months 8 days ago

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
DBV Technologies screens first participant in THRIVE Phase 2 study of VIASKIN Peanut Patch for infants with peanut allergy. Study aims to achieve ad lib consumption of dietary peanut in infants 6-12 months

DBV Technologies Peanut Allergy Viaskin Peanut Patch Infants THRIVE Phase 2
BRIEF

published on 05/13/2026 at 22:35, 2 months 28 days ago

DBV Technologies annonce les détails de sa prochaine assemblée générale

Allergies Alimentaires Informations Destinées Aux Actionnaires Technologies DBV Patch VIASKIN Assemblée Générale 2026
BRIEF

published on 05/13/2026 at 22:35, 2 months 28 days ago

DBV Technologies General Meeting on June 3, 2026

Shareholders General Assembly DBV Technologies Viaskin Pediatric Allergies
BRIEF

published on 05/13/2026 at 22:35, 2 months 28 days ago

DBV Technologies Announces Details for Upcoming General Meeting

DBV Technologies Food Allergies VIASKIN Patch General Meeting 2026 Shareholders Information
BRIEF

published on 05/13/2026 at 22:35, 2 months 28 days ago

Assemblée Générale de DBV Technologies le 3 juin 2026

Actionnaires Assemblée Générale DBV Technologies Viaskin Allergies Pédiatriques

Accesswire

Published on 08/11/2026 at 07:00, 1 hour 26 minutes ago

Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 7 hours 46 minutes ago

CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 8 hours 1 minute ago

Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 8 hours 51 minutes ago

NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 8 hours 56 minutes ago

Condor and Element79 Agree on Restructured Terms for Lucero Project

View all ACCESSWIRE

EQS Group

Published on 08/11/2026 at 08:05, 21 minutes ago

LX Pantos Strengthens Global ESG Leadership Through Its 2026 Sustainability Report
Published on 08/11/2026 at 08:00, 26 minutes ago

Cairn Homes Plc: Appointment of Pat Farrell as Independent Non-Executive Director
Published on 08/11/2026 at 08:00, 26 minutes ago

CANCOM SE continues to significantly strengthen profitability in H1.26
Published on 08/11/2026 at 07:42, 43 minutes ago

LAIQON AG: Strong revenue growth in the first half of 2026; increase in EBITDA in Q2 2026 by EUR 2.45 million to EUR +1.08 million
Published on 08/11/2026 at 07:30, 56 minutes ago

STS Group AG's first half of 2026 lays a strong foundation for meeting its full-year targets

Les Echos

Published on 08/10/2026 at 18:00, 14 hours 26 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 14 hours 26 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 14 hours 41 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 14 hours 41 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 20 hours 32 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE